190 related articles for article (PubMed ID: 25577946)
1. Accumulation of 24S-hydroxycholesterol in neuronal SK-N-BE cells treated with hexacosanoic acid (C26:0): argument in favor of 24S-hydroxycholesterol as a potential biomarker of neurolipotoxicity.
Zarrouk A; Hammami M; Moreau T; Lizard G
Rev Neurol (Paris); 2015 Feb; 171(2):125-9. PubMed ID: 25577946
[TBL] [Abstract][Full Text] [Related]
2. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
Lütjohann D; von Bergmann K
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
[TBL] [Abstract][Full Text] [Related]
3. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.
Vega GL; Weiner MF; Lipton AM; Von Bergmann K; Lutjohann D; Moore C; Svetlik D
Arch Neurol; 2003 Apr; 60(4):510-5. PubMed ID: 12707064
[TBL] [Abstract][Full Text] [Related]
4. Oxysterols and Alzheimer's disease.
Björkhem I; Heverin M; Leoni V; Meaney S; Diczfalusy U
Acta Neurol Scand Suppl; 2006; 185():43-9. PubMed ID: 16866910
[TBL] [Abstract][Full Text] [Related]
5. The role of 24S-hydroxycholesterol in Alzheimer's disease.
Kölsch H; Lütjohann D; von Bergmann K; Heun R
J Nutr Health Aging; 2003; 7(1):37-41. PubMed ID: 12679839
[TBL] [Abstract][Full Text] [Related]
6. Oxysterols as markers of neurological disease--a review.
Leoni V
Scand J Clin Lab Invest; 2009; 69(1):22-5. PubMed ID: 19199127
[TBL] [Abstract][Full Text] [Related]
7. New aspects of 24(S)-hydroxycholesterol in modulating neuronal cell death.
Noguchi N; Urano Y; Takabe W; Saito Y
Free Radic Biol Med; 2015 Oct; 87():366-72. PubMed ID: 26164631
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease.
Lukiw WJ
Expert Rev Neurother; 2006 May; 6(5):683-93. PubMed ID: 16734516
[TBL] [Abstract][Full Text] [Related]
9. Effects of cholesterol oxides on cell death induction and calcium increase in human neuronal cells (SK-N-BE) and evaluation of the protective effects of docosahexaenoic acid (DHA; C22:6 n-3).
Zarrouk A; Nury T; Samadi M; O'Callaghan Y; Hammami M; O'Brien NM; Lizard G; Mackrill JJ
Steroids; 2015 Jul; 99(Pt B):238-47. PubMed ID: 25656786
[TBL] [Abstract][Full Text] [Related]
10. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease.
Heverin M; Bogdanovic N; Lütjohann D; Bayer T; Pikuleva I; Bretillon L; Diczfalusy U; Winblad B; Björkhem I
J Lipid Res; 2004 Jan; 45(1):186-93. PubMed ID: 14523054
[TBL] [Abstract][Full Text] [Related]
11. Is 24(S)-hydroxycholesterol a potent modulator of cholesterol metabolism in Müller cells? An in vitro study about neuron to glia communication in the retina.
Léger-Charnay E; Masson EAY; Morala T; Martine L; Buteau B; Leclere L; Bretillon L; Gambert S
Exp Eye Res; 2019 Dec; 189():107857. PubMed ID: 31654618
[TBL] [Abstract][Full Text] [Related]
12. Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease.
Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Rao ML; Maier W; Björkhem I; von Bergmann K; Heun R
Neuroreport; 2000 Jun; 11(9):1959-62. PubMed ID: 10884051
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation.
Björkhem I; Lütjohann D; Diczfalusy U; Ståhle L; Ahlborg G; Wahren J
J Lipid Res; 1998 Aug; 39(8):1594-600. PubMed ID: 9717719
[TBL] [Abstract][Full Text] [Related]
14. 24S-hydroxycholesterol: Cellular effects and variations in brain diseases.
Sodero AO
J Neurochem; 2021 May; 157(4):899-918. PubMed ID: 33118626
[TBL] [Abstract][Full Text] [Related]
15. Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease.
Björkhem I; Lövgren-Sandblom A; Leoni V; Meaney S; Brodin L; Salveson L; Winge K; Pålhagen S; Svenningsson P
Neurosci Lett; 2013 Oct; 555():102-5. PubMed ID: 24035896
[TBL] [Abstract][Full Text] [Related]
16. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins.
Vega GL; Weiner M; Kölsch H; von Bergmann K; Heun R; Lutjohan D; Nguyen A; Moore C
Curr Alzheimer Res; 2004 Feb; 1(1):71-7. PubMed ID: 15975088
[TBL] [Abstract][Full Text] [Related]
17. The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron proteome.
Wang Y; Muneton S; Sjövall J; Jovanovic JN; Griffiths WJ
J Proteome Res; 2008 Apr; 7(4):1606-14. PubMed ID: 18303831
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls.
Schönknecht P; Lütjohann D; Pantel J; Bardenheuer H; Hartmann T; von Bergmann K; Beyreuther K; Schröder J
Neurosci Lett; 2002 May; 324(1):83-5. PubMed ID: 11983301
[TBL] [Abstract][Full Text] [Related]
19. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.
Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Buschfort R; Ptok U; Björkhem I; von Bergmann K; Heun R
J Psychiatr Res; 2002; 36(1):27-32. PubMed ID: 11755458
[TBL] [Abstract][Full Text] [Related]
20. Orphan Nuclear Receptor RORα Regulates Enzymatic Metabolism of Cerebral 24S-Hydroxycholesterol through CYP39A1 Intronic Response Element Activation.
Matsuoka H; Katayama M; Ohishi A; Miya K; Tokunaga R; Kobayashi S; Nishimoto Y; Hirooka K; Shima A; Michihara A
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
